Product References
Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer.
Nature
Xiao L,Parolia A,Qiao Y,Bawa P,Eyunni S,Mannan R,Carson SE,Chang Y,Wang X,Zhang Y,Vo JN,Kregel S,Simko SA,Delekta AD,Jaber M,Zheng H,Apel IJ,McMurry L,Su F,Wang R,Zelenka-Wang S,Sasmal S,Khare L,Mukherjee S,Abbineni C,Aithal K,Bhakta MS,Ghurye J,Cao X,Navone NM,Nesvizhskii AI,Mehra R,Vaishampayan U,Blanchette M,Wang Y,Samajdar S,Ramachandra M,Chinnaiyan AM
PA5-27157 was used in Immunohistochemistry to study the efficacy of proteolysis-targeting chimera degrader, AU-15330, in degradation of SWI/SNF ATPase subunits, SMARCA2 and SMARCA4.
Sat Jan 01 00:00:00 EST 2022
Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer.
Nature
Xiao L,Parolia A,Qiao Y,Bawa P,Eyunni S,Mannan R,Carson SE,Chang Y,Wang X,Zhang Y,Vo JN,Kregel S,Simko SA,Delekta AD,Jaber M,Zheng H,Apel IJ,McMurry L,Su F,Wang R,Zelenka-Wang S,Sasmal S,Khare L,Mukherjee S,Abbineni C,Aithal K,Bhakta MS,Ghurye J,Cao X,Navone NM,Nesvizhskii AI,Mehra R,Vaishampayan U,Blanchette M,Wang Y,Samajdar S,Ramachandra M,Chinnaiyan AM
PA5-27157 was used in Immunohistochemistry to study the efficacy of proteolysis-targeting chimera degrader, AU-15330, in degradation of SWI/SNF ATPase subunits, SMARCA2 and SMARCA4.
Sat Jan 01 00:00:00 EST 2022
STK11/LKB1 Loss of Function Is Associated with Global DNA Hypomethylation and S-Adenosyl-Methionine Depletion in Human Lung Adenocarcinoma.
Cancer research
Koenig MJ,Agana BA,Kaufman JM,Sharpnack MF,Wang WZ,Weigel C,Navarro FCP,Amann JM,Cacciato N,Arasada RR,Gerstein MB,Wysocki VH,Oakes C,Carbone DP
PA5-27157 was used in Immunocytochemistry to discover a novel association between LKB1 loss and widespread DNA demethylation.
Sun Aug 15 00:00:00 EDT 2021
Comprehensive Gene Expression Analyses of Immunohistochemically Defined Subgroups of Muscle-Invasive Urinary Bladder Urothelial Carcinoma.
International journal of molecular sciences
Kim B,Jang I,Kim K,Jung M,Lee C,Park JH,Kim YA,Moon KC
PA5-27157 was used in Immunohistochemistry to indicate that the CK5/6 positive subgroup exhibited high gene expression signature related to aggressive behavior and exhibited worse clinical outcome.
Sun Jan 10 00:00:00 EST 2021
PD-L1 Expression in Muscle-Invasive Urinary Bladder Urothelial Carcinoma According to Basal/Squamous-Like Phenotype.
Frontiers in oncology
Kim B,Lee C,Kim YA,Moon KC
PA5-27157 was used in Immunohistochemistry to evaluate PD-L1 expression by the SP142 and SP263 assays and classified the cases "positive" or "negative" according to the manufacturer's recommendations.
Thu Dec 31 00:00:00 EST 2020
Non-Muscle-Invasive Bladder Carcinoma with Respect to Basal Versus Luminal Keratin Expression.
International journal of molecular sciences
Jung M,Jang I,Kim K,Moon KC
PA5-27157 was used in Immunohistochemistry (Paraffin) to identify genetic signatures of NMIBC related to basal (K5/6) and luminal (K20) keratin expression.
Mon Oct 19 00:00:00 EDT 2020
Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer.
Nature
Parolia A,Cieslik M,Chu SC,Xiao L,Ouchi T,Zhang Y,Wang X,Vats P,Cao X,Pitchiaya S,Su F,Wang R,Feng FY,Wu YM,Lonigro RJ,Robinson DR,Chinnaiyan AM
Published figure using FOXA1 polyclonal antibody (Product # PA5-27157) in Western Blot
Mon Jul 01 00:00:00 EDT 2019
Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer.
Nature
Parolia A,Cieslik M,Chu SC,Xiao L,Ouchi T,Zhang Y,Wang X,Vats P,Cao X,Pitchiaya S,Su F,Wang R,Feng FY,Wu YM,Lonigro RJ,Robinson DR,Chinnaiyan AM
Published figure using FOXA1 polyclonal antibody (Product # PA5-27157) in Western Blot
Mon Jul 01 00:00:00 EDT 2019
Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer.
Nature
Parolia A,Cieslik M,Chu SC,Xiao L,Ouchi T,Zhang Y,Wang X,Vats P,Cao X,Pitchiaya S,Su F,Wang R,Feng FY,Wu YM,Lonigro RJ,Robinson DR,Chinnaiyan AM
Published figure using FOXA1 polyclonal antibody (Product # PA5-27157) in Western Blot
Mon Jul 01 00:00:00 EDT 2019
Androgen Receptor-Activated Enhancers Simultaneously Regulate Oncogene TMPRSS2 and lncRNA PRCAT38 in Prostate Cancer.
Cells
Chen Z,Song X,Li Q,Xie L,Guo T,Su T,Tang C,Chang X,Liang B,Huang D
Published figure using FOXA1 polyclonal antibody (Product # PA5-27157) in ChIP assay
Fri Aug 09 00:00:00 EDT 2019
Androgen Receptor-Activated Enhancers Simultaneously Regulate Oncogene TMPRSS2 and lncRNA PRCAT38 in Prostate Cancer.
Cells
Chen Z,Song X,Li Q,Xie L,Guo T,Su T,Tang C,Chang X,Liang B,Huang D
Published figure using FOXA1 polyclonal antibody (Product # PA5-27157) in ChIP assay
Fri Aug 09 00:00:00 EDT 2019
Androgen Receptor-Activated Enhancers Simultaneously Regulate Oncogene TMPRSS2 and lncRNA PRCAT38 in Prostate Cancer.
Cells
Chen Z,Song X,Li Q,Xie L,Guo T,Su T,Tang C,Chang X,Liang B,Huang D
Published figure using FOXA1 polyclonal antibody (Product # PA5-27157) in ChIP assay
Fri Aug 09 00:00:00 EDT 2019
Aberrant activation of CYR61 enhancers in colorectal cancer development.
Journal of experimental & clinical cancer research : CR
Xie L,Song X,Lin H,Chen Z,Li Q,Guo T,Xu T,Su T,Xu M,Chang X,Wang LK,Liang B,Huang D
Published figure using FOXA1 polyclonal antibody (Product # PA5-27157) in Western Blot
Wed May 22 00:00:00 EDT 2019
Transcriptional Analysis of Immunohistochemically Defined Subgroups of Non-Muscle-Invasive Papillary High-Grade Upper Tract Urothelial Carcinoma.
International journal of molecular sciences
Jung M,Lee JH,Kim B,Park JH,Moon KC
PA5-27157 was used in Immunohistochemistry to facilitate the application of easily accessible prognostic biomarkers in practice.
Tue Jan 29 00:00:00 EST 2019
Analysis of the androgen receptor-regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression.
Nature genetics
Zhang Y,Pitchiaya S,Cieślik M,Niknafs YS,Tien JC,Hosono Y,Iyer MK,Yazdani S,Subramaniam S,Shukla SK,Jiang X,Wang L,Liu TY,Uhl M,Gawronski AR,Qiao Y,Xiao L,Dhanasekaran SM,Juckette KM,Kunju LP,Cao X,Patel U,Batish M,Shukla GC,Paulsen MT,Ljungman M,Jiang H,Mehra R,Backofen R,Sahinalp CS,Freier SM,Watt AT,Guo S,Wei JT,Feng FY,Malik R,Chinnaiyan AM
PA5-27157 was used in Chromatin immunoprecipitation to support a role for ARLNC1 in maintaining a positive feedback loop that potentiates AR signaling during prostate cancer progression and identify ARLNC1 as a novel therapeutic target.
Fri Jun 01 00:00:00 EDT 2018
FOXA1 knock-out via CRISPR/Cas9 altered Casp-9, Bax, CCND1, CDK4, and fibronectin expressions in LNCaP cells.
Experimental biology and medicine (Maywood, N.J.)
Albayrak G,Konac E,Ugras Dikmen A,Bilen CY
Published figure using FOXA1 polyclonal antibody (Product # PA5-27157) in Western Blot
Wed Aug 01 00:00:00 EDT 2018
FOXA1 knock-out via CRISPR/Cas9 altered Casp-9, Bax, CCND1, CDK4, and fibronectin expressions in LNCaP cells.
Experimental biology and medicine (Maywood, N.J.)
Albayrak G,Konac E,Ugras Dikmen A,Bilen CY
Published figure using FOXA1 polyclonal antibody (Product # PA5-27157) in Western Blot
Wed Aug 01 00:00:00 EDT 2018